Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT04922281

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04922281
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04922281. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-28 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
Acronym
ICMREDUCE-AF
Condition
Cardiovascular Diseases
Condition
Heart Diseases
Condition
Arrhythmias, Cardiac
Condition
Pathologic Processes
Intervention (Device)
Insertable Cardiac Monitor or external non-invasive LT-ECG patch
Lead sponsor
University of Rochester (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct04922281
Content hash
2015bec3eed04da66558d0c15e1c02ea930bb663af7bee537e90ae8debe77e21